Drug Regulation: FDA's Computer Systems Need To Be Better Managed

Weekly Updates

LegiStorm is constantly adding new information on the people, places and reports in our database. In the past week, LegiStorm added:

1739 new people
124 new organizations
991 new photos
2117 job history records for people in our database
641 education records for people in our database
2487 contact addresses, emails and URLs (LinkedIn, Facebook, etc.)
107 new policy reports
3 new trips to our privately funded travel database
323 new personal financial disclosures
6604 new press releases
1 new town hall
28 new hearings

Caught Our Eye Rss

Longtime House staffer heads to trade org

by Heavyn Lester on 11/13/2024
Members of Congress more likely to be veterans

by Heavyn Lester on 11/12/2024
Native American underrepresentation in Congress will continue in 2025

by Heavyn Lester on 11/04/2024
Civil rights leads the fastest growing issues in 2024

by Caleb Mynatt on 10/28/2024
Oil trade group picks up Senate staffer

by Heavyn Lester on 10/23/2024

» More from Caught Our Eye

Follow @LegiStorm

LegiStorm adds House Q2 salaries and expenses

2024-09-05
Latest Senate salary and expense records published

2024-06-10
LegiStorm adds House Q1 salaries and expenses

2024-06-05
LegiStorm adds Q4 salary analytics and turnover data

2024-03-14

» More from our DevBlog

Healthcare: Monthly people moves

by Axios on 11/01/2024
An exodus of top staffers from Yadira Caraveo’s congressional office

by The Colorado Sun on 10/15/2024
Yadira Caraveo has among the highest staff turnover rates in Congress

by The Colorado Sun on 10/15/2024
'I'm advocating Christian nationalism': Josh Hawley's ties to Project 2025 exposed

by Raw Story on 10/15/2024

Premium Download PDF Now (66 pages)

Report Type	Reports and Testimonies
Report Date	Sept. 5, 1986
Report No.	IMTEC-86-32
Subject	Food and drug law Health care services Information resources management Information systems Pharmaceutical industry Pharmacological research Information management FDA Adverse Drug Reaction Reporting System FDA Astro-IV Drug Information System FDA New Drug Evaluation/Management Information System Drugs Computer systems

Summary:

In response to a congressional request, GAO reviewed the Food and Drug Administration's (FDA) management and use of drug information to determine whether its primary drug information systems were: (1) accurate and complete; and (2) useful to reviewers in facilitating the evaluation of new drug applications.

GAO found that, despite some improvement since 1983: (1) the three principal FDA drug information systems are inaccurate and one is incomplete; (2) these systems are not useful to most FDA drug reviewers because they are unreliable and do not meet user needs in facilitating the evaluation of new drug applications; and (3) these systems' inadequacies and other information management deficiencies may result in delays in identifying unsafe drugs that are already on the market and in the approval and marketing of new drugs that are unsafe, ineffective, or both. GAO believes that FDA difficulties with its drug information systems will continue because the agency has not effectively managed its information resources.

« Return to search Government Accountability Office reports

Weekly Updates

Caught Our Eye Rss

Social Media

DevBlog Rss

In the News

Drug Regulation: FDA's Computer Systems Need To Be Better Managed